Markers of inflammation are cross-sectionally associated with microvascular complications and cardiovascular disease in type 1 diabetes - The EURODIAB Prospective Complications Study

Diabetologia

Volumn 48, Issue 2, 2005, Pages 370-378

  Schram, M T ^a,b   Chaturvedi, N ^c   Schalkwijk, C G ^a,b   Fuller, J H ^d   Stehouwer, C D A ^a,b,e  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Advanced glycation endproducts; C reactive protein; Cardiovascular disease; Diabetes; Interleukin 6; Microvascular complications; Tumour necrosis factor

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CASE CONTROL STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIABETIC MICROANGIOPATHY; DIABETIC RETINOPATHY; DISEASE MARKER; FEMALE; FOLLOW UP; HUMAN; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; MACROALBUMINURIA; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; PRIORITY JOURNAL; PROLIFERATIVE RETINOPATHY; PROSPECTIVE STUDY; PROTEINURIA;

ADULT; BIOLOGICAL MARKERS; BLOOD PRESSURE; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 1; DIABETIC ANGIOPATHIES; DIABETIC RETINOPATHY; FEMALE; GLYCOSYLATION END PRODUCTS, ADVANCED; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INFLAMMATION; MALE; MICROCIRCULATION;

EID: 17444405235     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-004-1628-8     Document Type: Article

References (38)

1. Chaturvedi N, Bandinelli S, Mangili R et al (2001) Microalbuminuria in type 1 diabetes: rates, risk factors and glycemic threshold. Kidney Int 60:219-227
2. Chaturvedi N, Sjoelie AK, Porta M et al (2001) Markers of insulin resistance are strong risk factors for retinopathy incidence in type 1 diabetes. Diabetes Care 24:284-289
3. Ridker PM, Hennekens CH, Buring JE, Rifai N (2000) C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 342:836-843
4. Schalkwijk CG, Poland DC, van Dijk W et al (1999) Plasma concentration of C-reactive protein is increased in type I diabetic patients without clinical macroangiopathy and correlates with markers of endothelial dysfunction: evidence for chronic inflammation. Diabetologia 42:351-357
5. Schmidt AM, Hori O, Chen JX et al (1995) Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of diabetes. J Clin Invest 96:1395-1403
6. The EURODIAB IDDM Complications Study Group (1994) Microvascular and acute complications in IDDM patients: the EURODIAB IDDM complications study. Diabetologia 37:278-285
7. Chaturvedi N, Fuller JH, Taskinen MR, The EURODIAB Prospective Complications Study Group (2001) Differing associations of lipid and lipoprotein disturbances with the macrovascular and microvascular complications of type 1 diabetes. Diabetes Care 24:2071-2077
8. Aldington SJ, Kohner EM, Meuer S, Klein R, Sjolie AK, The EURODIAB IDDM Complications Study Group (1995) Methodology for retinal photography and assessment of diabetic retinopathy: the EURODIAB IDDM complications study. Diabetologia 38:437-444
9. Koivisto VA, Stevens LK, Mattock M et al (1996) Cardiovascular disease and its risk factors in IDDM in Europe. EURODIAB IDDM Complications Study Group. Diabetes Care 19:689-697
10. Smulders RA, Stehouwer CD, Schalkwijk CG, Donker AJ, Van Hinsbergh VW, TeKoppele JM (1998) Distinct associations of HbA1c and the urinary excretion of pentosidine, an advanced glycosylation end-product, with markers of endothelial function in insulin-dependent diabetes mellitus. Thromb Haemost 80:52-57
11. ε- (carboxyethyl)lysine in type 1 diabetic patients with impaired renal function: correlation with markers of endothelial dysfunction. Nephrol Dial Transplant 19:631-636
12. Schram MT, Chaturvedi N, Schalkwijk C et al (2003) Vascular risk factors and markers of endothelial function as determinants of inflammatory markers in type 1 diabetes: the EURODIAB Prospective Complications Study. Diabetes Care 26:2165-2173
13. Ling BN, Matsunaga H, Ma H, Eaton DC (1995) Role of growth factors in mesangial cell ion channel regulation. Kidney Int 48:1158-1166
14. Kim F, Gallis B, Corson MA (2001) TNF-alpha inhibits flow and insulin signaling leading to NO production in aortic endothelial cells. Am J Physiol, Cell Physiol 280:C1057-C1065
15. Oragui EE, Nadel S, Kyd P, Levin M (2000) Increased excretion of urinary glycosaminoglycans in meningococcal septicemia and their relationship to proteinuria. Crit Care Med 28:3002-3008
16. Utimura R, Fujihara CK, Mattar AL, Malheiros DM, De LNI, Zatz R (2003) Mycophenolate mofetil prevents the development of glomerular injury in experimental diabetes. Kidney Int 63:209-216
17. Remuzzi G, Bertani T (1998) Pathophysiology of progressive nephropathies. N Engl J Med 339:1448-1456
18. Joles JA, Kunter U, Janssen U et al (2000) Early mechanisms of renal injury in hypercholesterolemic or hypertriglyceridemic rats. J Am Soc Nephrol 11:669-683
19. Ross R (1999) Atherosclerosis - an inflammatory disease. N Engl J Med 340:115-126
20. Schmidt AM, Stern DM (2001) Receptor for age (RAGE) is a gene within the major histocompatibility class III region: implications for host response mechanisms in homeostasis and chronic disease. Front Biosci 6:D1151-D1160
21. Sugiyama S, Miyata T, Ueda Y et al (1998) Plasma levels of pentosidine in diabetic patients: an advanced glycation end product. J Am Soc Nephrol 9:1681-1688
22. Beisswenger PJ, Moore LL, Curphey TJ (1993) Relationship between glycemic control and collagen-linked advanced glycosylation end products in type I diabetes. Diabetes Care 16:689-694
23. Yoshihara K, Nakamura K, Kanai M et al (1998) Determination of urinary and serum pentosidine and its application to elder patients. Biol Pharm Bull 21:1005-1008
24. Bierhaus A, Hofmann MA, Ziegler R, Nawroth PP (1998) AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE concept. Cardiovasc Res 37:586-600
25. Forbes JM, Soulis T, Thallas V et al (2001) Renoprotective effects of a novel inhibitor of advanced glycation. Diabetologia 44:108-114
26. Franken AA, Derkx FH, Man in't Veld AJ et al (1990) High plasma prorenin in diabetes mellitus and its correlation with some complications. J Clin Endocrinol Metab 71:1008-1015
27. Einer SG, Elner VM, Jaffe GJ, Stuart A, Kunkel SL, Strieter RM (1995) Cytokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy. Curr Eye Res 14:1045-1053
28. Limb GA, Hollifield RD, Webster L, Charteris DG, Chignell AH (2001) Soluble TNF receptors in vitreoretinal proliferative disease. Invest Ophthalmol Vis Sci 42:1586-1591
29. Claudio L, Martiney JA, Brosnan CF (1994) Ultrastructural studies of the blood-retina barrier after exposure to interleukin-1 beta or tumor necrosis factor-alpha. Lab Invest 70:850-861
30. Porta M (1996) Endothelium: the main actor in the remodelling of the retinal microvasculature in diabetes. Diabetologia 39:739-744
31. Kohner EM, Patel V, Rassam SM (1995) Role of blood flow and impaired autoregulation in the pathogenesis of diabetic retinopathy. Diabetes 44:603-607
32. Chakravarthy U, Gardiner TA (1999) Endothelium-derived agents in pericyte function/dysfunction. Prog Retin Eye Res 18:511-527
33. Joussen AM, Poulaki V, Mitsiades N et al (2002) Nonsteroidal anti-inflammatory drugs prevent early diabetic retinopathy via TNF-alpha suppression. FASEB J 16:438-440
34. Yudkin JS, Kumari M, Humphries SE, Mohamed-Ali V (2000) Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? Atherosclerosis 148:209-214
35. Kreisberg RA (1998) Diabetic dyslipidemia. Am J Cardiol 82:67U-73U
36. Stehouwer CD, Gall MA, Twisk JW, Knudsen E, Emeis JJ, Parving HH (2002) Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: progressive, interrelated, and independently associated with risk of death. Diabetes 51:1157-1165
37. Ebeling P, Koivisto VA (1997) Occurrence and interrelationships of complications in insulin-dependent diabetes in Finland. Acta Diabetol 34:33-38
38. Baynes JW, Thorpe SR (1999) Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes 48:1-9